Trademark Overview
On Wednesday, May 22, 2024, a trademark application was filed for DNAE with the United States Patent and Trademark Office. The USPTO has given the DNAE trademark a serial number of 98563271. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, December 10, 2024. This trademark is owned by DNAe Group Holdings Limited. The DNAE trademark is filed in the Computer & Software Products & Electrical & Scientific Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
(Based on 44(e))(Based on Intent To Use) ; Apparatus for DNA and RNA amplification and sequencing for research purposes; apparatus for on-chip DNA and RNA amplification sequencing and measurement; computer software for the diagnosis of sepsis, infectious diseases and associated antimicrobial resistance, cancer and other medical conditions; semiconductors and microchips for sequencing and measurement of DNA and RNA for scientific medical research and veterinary purposes; all for scientific research purposes, not pertaining to the dnaE gene; (Based on Intent To Use) Scientific apparatus and instruments; scientific research and laboratory apparatus; apparatus for conducting PCR analysis; apparatus for semiconductor sequencing; silicon transistors; microchips; data processing equipment; computer software; bioinformatics software; software for microbial pathogen detection and identification; all for scientific research purposes, not pertaining to the dnaE gene
(Based on 44(e))(Based on Intent To Use) ; DNA and RNA screening for medical purposes; medical laboratory services for the analysis of samples taken from patients; provision of information relating to the analysis of DNA and RNA; consultancy and advisory services relating to the aforesaid services; (Based on Intent To Use) Medical and veterinary services; healthcare services; genetic and blood testing, sequencing and measuring services; genetic testing for medical purposes; medical diagnostic testing, monitoring and reporting services; consultancy and advisory services relating to the aforesaid services
(Based on 44(e))(Based on Intent To Use) ; Apparatus for providing diagnostic sequencing of blood samples, DNA and RNA; apparatus for the diagnosis and monitoring of sepsis and infectious diseases and associated antimicrobial resistance, cancer and other medical conditions; apparatus for DNA and RNA testing for medical purposes; apparatus for the diagnosis and monitoring of cancer; apparatus for testing blood samples, cancer cells, DNA, RNA and protein; apparatus for PCR analysis and DNA and RNA sequencing for medical and veterinary purposes; semiconductors and microchips for sequencing and measurement of DNA and RNA for medical and veterinary purposes; (Based on Intent To Use) Medical and veterinary apparatus and instruments; apparatus for microbial pathogen detection and identification; medical diagnostic apparatus for taking and storing blood samples; vials and other containers in the nature of tubes for blood and other medical sample collection
(Based on 44(e))(Based on Intent To Use) ; Laboratory services in the testing, sequencing and measurement of DNA and RNA; data storage services; consultancy and advisory services relating to the aforesaid services; none of the preceding pertaining to the dnaE gene; (Based on Intent To Use) Scientific and technological services; medical laboratory services; laboratory analysis; consultancy and advisory services related to the aforesaid services; none of the preceding pertaining to the dnaE gene
